<div id="readability-page-1">Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings from Top Wall Street analysts. Each stock offers solid upside potential, supported by fresh Buy calls.<h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. </li><li> Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off </li></ul> For more stock ideas, check out TipRanks' Analyst Top Stocks tool, which tracks the latest Buy ratings from top analysts in real time. Here are today's top analyst-backed stock picks. Click on any ticker to research the company before deciding whether to add it to your portfolio. <ul> <li>Nvidia (NVDA) – This is a major chip company that makes graphics processors and AI chips used in data centers, cloud systems, and many new AI tools. Today, Bernstein analyst Stacy Rasgon maintained a Buy rating on the stock with a price target of $275 per share. Interestingly, 39 out of the 40 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 39.05%. </li> <li>Corcept Therapeutics (CORT) – This is a biotech company that develops drugs for metabolic, oncologic, and neurological disorders, including treatments that target the cortisol pathway. Today, Canaccord Genuity analyst Edward Nash maintained a Buy rating on the stock with a price target of $140 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 63.09%. </li> <li>Syndax Pharmaceuticals (SNDX) – This is a clinical-stage biotech company developing cancer therapies that aim to improve outcomes in hard-to-treat tumors. Today, H.C. Wainwright analyst Andres Y. Maldonado maintained a Buy rating on the stock with a price target of $40 per share. In the last three months, all eight Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 92.34%.</li> </ul> <h2>Who Are the Top Analysts? </h2> TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks' Top Wall Street Analysts page. </div>

SNDX

NVDA

CORT

Top analysts recommend three 'Strong Buy' stocks: Nvidia (NVDA), Corcept Therapeutics (CORT), and Syndax Pharmaceuticals (SNDX). Nvidia has a price target of $275 with a 39.05% upside, Corcept Therapeutics has a $140 target with a 63.09% upside, and Syndax Pharmaceuticals has a $40 target with a 92.34% upside. TipRanks offers tools for tracking analyst ratings and insights.

- Recent analyst updates identify three stocks with Strong Buy ratings from top Wall Street analysts, indicating solid upside potential.  
- Nvidia (NVDA), Corcept Therapeutics (CORT), and Syndax Pharmaceuticals (SNDX) have all received Buy ratings, with implied upsides of approximately 39.05%, 63.09%, and 92.34%, respectively.  
- TipRanks provides insights into analyst performance, ranking them based on the success rates of their ratings and average returns.

3 'Strong Buy' Stocks to Buy Today, 12/9/2025, According to Top Analysts